Product lifecycle solutions
We deliver intelligent insights through the pharmaceutical product lifecycle
From early-stage commercial opportunity assessment and market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and post-launch tracking, we can support pharma with intelligent market research and consulting solutions through the lifecycle of the brand.
Senior level involvement
Our large, senior team of over 40 Directors are involved at every stage of the project.
High quality research
Our outputs answer the key business questions with a clear, direct recommendation, supported by the research evidence.
Communication and flexibility
We keep clients informed through weekly updates and respond quickly to needs and deadlines.
A creative approach
We offer custom approaches, not branded solutions, so our research design is always creative and fresh.
- Some example case studiesHow a combined qual quant approach provided our client with integral insights for continued product development in the HIV space
Our client was looking to develop novel HIV prevention products, and wanted to explore different formulation options.read more »How patient insights were brought to life with graphic novel outputs
The challenge:Our client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks; the main burden of disease is not just the acute attacks themselves, but the unpredictability of these attacks, with implications for daily life that include high background stress / worry levels and a great deal of adjustments to daily life. Our client’s new…read more »How Paediatricians and GPs revealed key insights to help develop a science story for a child nutritional supplement
The challenge:Our client needed to develop a science story in order to increase uptake for their child nutritional supplement. Research was required in order to define the patient target, frame the challenge of growth delays to be an effective call to action, articulate objectives for the product and the best way to express its value proposition. The solution:We conducted a mix of “workshop-style” focus groups…read more »
- Our latest white papersAre dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.read more »Punching above your weight: Combining behavioural and attitudinal data to strengthen segmentations
In this paper we examine the differences between behavioural and attitudinal approaches to segmentation and outline how integration of the two can best be achieved to strengthen segmentation solutionsread more »